BioSpace News Archive

Drug Development

Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome

Emalex Biosciences announced the closing of an upsized and oversubscribed $250 million Series D funding round that will fund a Phase 3 clinical trial and potential commercialization of a new class of drug for patients with Tourette Syndrome.

November 3, 2022
·
5 min read
Business

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

Zhongchao Inc. today announced that one of the China operating entities of which the Company consolidates the financial results with through certain contractual arrangements Chongqing Xinjiang Pharmaceutical Co., Ltd. (“Xinjiang Pharmaceutical”) has obtained a series of pharmaceutical related licenses.

November 3, 2022
·
5 min read
Business

MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update

Mind Medicine today announced that it will host its earnings call on Thursday, November 10, 2022, at 8:30 a.m. EDT to discuss its financial results for the quarter ended September 30, 2022 and provide a business update.

November 3, 2022
·
1 min read
Business

Elevation Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress

Elevation Oncology, Inc. today announced financial results for the quarter ended September 30, 2022, and highlighted recent progress.

November 3, 2022
·
8 min read
Biotech Bay

Medable Unifies and Simplifies Consent Management for Global Decentralized and Hybrid Trials

Medable Inc. today announced the availability of its Total Consent offering, a fully enabled SaaS electronic consent management solution compatible with every clinical trial, in more than 120 locales around the globe.

November 3, 2022
·
4 min read
Genetown

Akoya to Participate at Three Upcoming Investor Conferences - November 03, 2022

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be participating in three upcoming investor conferences.

November 3, 2022
·
1 min read
Business

Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10, 2022

Eyenovia, Inc. announced that the Company will release financial results for the third quarter ended September 30, 2022 on Thursday, November 10, 2022, after the markets close.

November 3, 2022
·
1 min read
Business

Merus Announces Financial Results for the Third Quarter 2022 and Provides Business Update

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced financial results for the third quarter that ended September 30, 2022 and provided a business update.

November 3, 2022
·
17 min read
Business

Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update

Selecta Biosciences, Inc. reported financial results for the third quarter ended September 30, 2022 and provided a business update.

November 3, 2022
·
14 min read
Business

Daré Bioscience to Host Third Quarter 2022 Financial Results and Company Update Conference Call and Webcast on November 10, 2022

Daré Bioscience, Inc. announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, November 10, 2022, to review its financial results for the quarter ended September 30, 2022 and to provide a Company update.

November 3, 2022
·
3 min read